(Q34586834)

3 August 2017

1 reference

title

Orphan nuclear receptors find a home in the arterial wall (English)

1 reference

3 August 2017

2

Peter Tontonoz

1 reference

3 August 2017

Bryan A Laffitte

1

1 reference

3 August 2017

language of work or name

1 reference

1 May 2002

1 reference

Current Atherosclerosis Reports

3 August 2017

1 reference

3 August 2017

4

1 reference

3 August 2017

213-221

1 reference

3 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-002-0022-6

3 August 2017

0 references

cites work

Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0022-6

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0022-6

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0022-6

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0022-6

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0022-6

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0022-6

Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0022-6

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0022-6

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

12 December 2020

Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers

1 reference

12 December 2020

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

1 reference

12 December 2020

Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma

1 reference

12 December 2020

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.

1 reference

12 December 2020

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

12 December 2020

PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice

1 reference

12 December 2020

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

1 reference

12 December 2020

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

1 reference

12 December 2020

Orphan nuclear receptors: shifting endocrinology into reverse

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

12 December 2020

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

12 December 2020

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

12 December 2020

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

12 December 2020

Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols

1 reference

12 December 2020

1 reference

12 December 2020

Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]).

1 reference

12 December 2020

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

12 December 2020

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

12 December 2020

The nuclear receptor superfamily: the second decade

1 reference

12 December 2020

Atherosclerosis. the road ahead

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor

1 reference

12 December 2020

Autoregulation of the human liver X receptor alpha promoter

1 reference

12 December 2020

Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes

1 reference

12 December 2020

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

12 December 2020

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

12 December 2020

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

12 December 2020

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

12 December 2020

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

1 reference

12 December 2020

Role of LXRs in control of lipogenesis

1 reference

12 December 2020

Transcriptional regulation of adipogenesis

1 reference

12 December 2020

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

1 reference

12 December 2020

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

12 December 2020

27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells

1 reference

12 December 2020

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

12 December 2020

Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency

1 reference

12 December 2020

Activation of PPARdelta alters lipid metabolism in db/db mice.

1 reference

12 December 2020

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

12 December 2020

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

12 December 2020

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

1 reference

12 December 2020

The role of orphan nuclear receptors in the regulation of cholesterol homeostasis

1 reference

12 December 2020

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

12 December 2020

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway

1 reference

12 December 2020

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

12 December 2020

10.1007/S11883-002-0022-6

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1043076138

0 references

Fatcat ID

release_ffnaxiq3bnfqhev24e7zy74bwy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ffnaxiq3bnfqhev24e7zy74bwy

24 November 2022

mapped directly with Wikidata item

1 reference